Literatura académica sobre el tema "Pharmacokinetics"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Pharmacokinetics".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Pharmacokinetics"
Iorio, Alfonso. "Using pharmacokinetics to individualize hemophilia therapy". Hematology 2017, n.º 1 (8 de diciembre de 2017): 595–604. http://dx.doi.org/10.1182/asheducation-2017.1.595.
Texto completoKamp, Jasper, Erik Olofsen, Thomas K. Henthorn, Monique van Velzen, Marieke Niesters y Albert Dahan. "Ketamine Pharmacokinetics". Anesthesiology 133, n.º 6 (30 de septiembre de 2020): 1192–213. http://dx.doi.org/10.1097/aln.0000000000003577.
Texto completoJeong, Seung-Hyun, Ji-Hun Jang y Yong-Bok Lee. "Pharmacokinetic Comparison between Methotrexate-Loaded Nanoparticles and Nanoemulsions as Hard- and Soft-Type Nanoformulations: A Population Pharmacokinetic Modeling Approach". Pharmaceutics 13, n.º 7 (9 de julio de 2021): 1050. http://dx.doi.org/10.3390/pharmaceutics13071050.
Texto completoGrzegorzewski, Jan, Janosch Brandhorst, Kathleen Green, Dimitra Eleftheriadou, Yannick Duport, Florian Barthorscht, Adrian Köller, Danny Yu Jia Ke, Sara De Angelis y Matthias König. "PK-DB: pharmacokinetics database for individualized and stratified computational modeling". Nucleic Acids Research 49, n.º D1 (5 de noviembre de 2020): D1358—D1364. http://dx.doi.org/10.1093/nar/gkaa990.
Texto completoAlbitar, Orwa, Sabariah Noor Harun, Hadzliana Zainal, Baharudin Ibrahim y Siti Maisharah Sheikh Ghadzi. "Population Pharmacokinetics of Clozapine: A Systematic Review". BioMed Research International 2020 (8 de enero de 2020): 1–10. http://dx.doi.org/10.1155/2020/9872936.
Texto completoTang, Bo-Hao, Yue-E. Wu, Chen Kou, Yu-Jie Qi, Hui Qi, Hai-Yan Xu, Stephanie Leroux et al. "Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Neonates and Young Infants". Antimicrobial Agents and Chemotherapy 63, n.º 2 (3 de diciembre de 2018): e02336-18. http://dx.doi.org/10.1128/aac.02336-18.
Texto completoEgan, Talmage D., Bernou Huizinga, Samir K. Gupta, Rudy L. Jaarsma, Richard J. Sperry, James B. Yee y Keith T. Muir. "Remifentanil Pharmacokinetics in Obese versus Lean Patients". Anesthesiology 89, n.º 3 (1 de septiembre de 1998): 562–73. http://dx.doi.org/10.1097/00000542-199809000-00004.
Texto completoStepensky, David. "Pharmacokinetics of Toxin-Derived Peptide Drugs". Toxins 10, n.º 11 (20 de noviembre de 2018): 483. http://dx.doi.org/10.3390/toxins10110483.
Texto completoLi, Qiao, Yan Yang, Ting Zhou, Rui Wang, Na Li, Min Zheng, Yuan-Yuan Li et al. "A Compositive Strategy to Study the Pharmacokinetics of TCMs: Taking Coptidis Rhizoma, and Coptidis Rhizoma-Glycyrrhizae Radix et Rhizoma as Examples". Molecules 23, n.º 8 (15 de agosto de 2018): 2042. http://dx.doi.org/10.3390/molecules23082042.
Texto completoToja-Camba, Francisco José, Nerea Gesto-Antelo, Olalla Maroñas, Eduardo Echarri Arrieta, Irene Zarra-Ferro, Miguel González-Barcia, Enrique Bandín-Vilar et al. "Review of Pharmacokinetics and Pharmacogenetics in Atypical Long-Acting Injectable Antipsychotics". Pharmaceutics 13, n.º 7 (23 de junio de 2021): 935. http://dx.doi.org/10.3390/pharmaceutics13070935.
Texto completoTesis sobre el tema "Pharmacokinetics"
Chigutsa, Emmanuel. "Population pharmacokinetics and pharmacokinetic-pharmacodyamic modeling of antitubercular drugs". Doctoral thesis, University of Cape Town, 2013. http://hdl.handle.net/11427/3275.
Texto completoIncludes bibliographical references.
The pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in 78 patients with tuberculosis were described using non-linear mixed effects modeling. Pharmacodynamic data was comprised of weekly sputum liquid culture (using mycobacterial growth indicator tubes) time to detection results from 144 patients during the first 2 months of treatment. The effect of drug exposure on patient outcomes was investigated. To determine the adequacy of ofloxacin drug exposure, the probability of attaining the required area-under-the-curve to minimum inhibitory concentration ratio (AUC/MIC) of ofloxacin was determined in 65 patients on treatment for multidrug resistant tuberculosis. To improve efficiency in the clinical development of new drug regimens, clinical trial simulation was used to determine the optimal study design for a study investigating the efficacy of a new antitubercular drug regimen. The SLCO1B1 rs4149032 polymorphism existed at a high frequency of 0.70 in South Africans and resulted in a 28% decrease in bioavailability of rifampicin. The rifampicin peak concentration was a significant predictor of the 2 month treatment outcomes. A semimechanistic time to event model was developed to analyze days to positivity (time to detection) data. The model was comprised of a biexponential decay model describing bacillary decline in sputum from patients, followed by a logistic model with a lag time for growth of the mycobacteria in liquid culture. For the current 800 mg daily dose of ofloxacin, the probability of attaining an AUC/MIC target ratio of at least 100 was only 0.45. Based on clinical trial simulation, the optimum parallel study design was comprised of 125 study participants in each of 2 arms to achieve a study power of at least 80%. Increasing the study length beyond 42 days reduced study power perhaps due to increased amounts of censored data. Higher doses of rifampicin are required in the majority of South African patients with tuberculosis. A novel pharmacodynamic model of tuberculosis treatment is presented, which can be used for investigation of covariates such as drug exposure. Ofloxacin should be replaced with a more potent fluoroquinolone for treatment of multidrug resistant tuberculosis. Clinical trials should not be unduly long otherwise this may compromise study power.
Ulrich-Oppliger, Brigitte Madeleine. "Pharmacokinetics /". Bern, 1992. http://www.ub.unibe.ch/content/bibliotheken_sammlungen/sondersammlungen/dissen_bestellformular/index_ger.html.
Texto completoCharter, Mark Keith. "Maximum entropy pharmacokinetics". Thesis, University of Cambridge, 1989. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.316691.
Texto completoSmith, Jennifer Lisa. "Pharmacokinetics of methylamines". Thesis, Massachusetts Institute of Technology, 1992. http://hdl.handle.net/1721.1/12906.
Texto completoKhosravan, Reza. "Nonlinear pharmacokinetics of diltiazem". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1999. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape9/PQDD_0030/NQ46865.pdf.
Texto completoAl-Mustafa, Z. H. "Methotrexate pharmacokinetics and toxicity". Thesis, University of Newcastle Upon Tyne, 1988. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.383988.
Texto completoWoodhouse, Jennifer Ann. "Plutonium pharmacokinetics and blood biochemistry". Thesis, University of Central Lancashire, 1997. http://clok.uclan.ac.uk/20148/.
Texto completoSmith, Adam John. "Modulating the Pharmacokinetics of Bioflavonoids". Scholar Commons, 2012. http://scholarcommons.usf.edu/etd/4226.
Texto completoHarper, Kenneth W. "Pharmacokinetics of methohexitone and midazolam". Thesis, Queen's University Belfast, 1986. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.254195.
Texto completoEvans, Gary Lee. "Pharmacokinetics and metabolism of lacidipine". Thesis, University of Hertfordshire, 1993. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.387196.
Texto completoLibros sobre el tema "Pharmacokinetics"
Pecile, A. y A. Rescigno, eds. Pharmacokinetics. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4684-5463-5.
Texto completoRiviere, Jim E. Comparative pharmacokinetics. Chichester, West Sussex: Wiley-Blackwell, 2011.
Buscar texto completoKrishna, Devarakonda Rama y Ulrich Klotz. Clinical Pharmacokinetics. Berlin, Heidelberg: Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-75623-8.
Texto completoRiviere, Jim E. Comparative Pharmacokinetics. Oxford, UK: Wiley-Blackwell, 2011. http://dx.doi.org/10.1002/9780470959916.
Texto completoDavies, Neal M. y Jaime A. Yáñez, eds. FLAVONOID PHARMACOKINETICS. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2012. http://dx.doi.org/10.1002/9781118468524.
Texto completoWu, Baojian, Danyi Lu y Dong Dong, eds. Circadian Pharmacokinetics. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-8807-5.
Texto completoJ, Breen Philip, ed. Basic pharmacokinetics. London: Pharmaceutical Press, 2009.
Buscar texto completo1943-, Shroot B., Schaefer H. 1935- y Centre international de recherches dermatologiques., eds. Skin pharmacokinetics. Basel: Karger, 1987.
Buscar texto completoKällén, Anders. Computational pharmacokinetics. Boca Raton, FL: Chapman & Hall/CRC, 2008.
Buscar texto completoKällén, Anders. Computational pharmacokinetics. Boca Raton: Taylor & Francis, 2007.
Buscar texto completoCapítulos de libros sobre el tema "Pharmacokinetics"
Gladtke, Erich. "History of Pharmacokinetics". En Pharmacokinetics, 1–9. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4684-5463-5_1.
Texto completoMetzler, Carl M. "Equivalence of Bioavailability and Efficacy in Drug Testing". En Pharmacokinetics, 215–25. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4684-5463-5_10.
Texto completoThakur, Ajit K. "Modeling and Risk Assessment of Carcinogenic Dose-Response". En Pharmacokinetics, 227–44. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4684-5463-5_11.
Texto completoBass, Ludvik y Susan M. Pond. "The Puzzle of Rates of Cellular Uptake of Protein-Bound Ligands". En Pharmacokinetics, 245–69. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4684-5463-5_12.
Texto completoMordenti, Joyce. "A Pharmacokinetic Equation Guide for Clinicians". En Pharmacokinetics, 271–89. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4684-5463-5_13.
Texto completoWagner, John G. "Pharmacokinetic Studies in Man". En Pharmacokinetics, 291–322. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4684-5463-5_14.
Texto completoBreuer, Francesco. "Metabolic Models in Radiation Protection". En Pharmacokinetics, 323–35. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4684-5463-5_15.
Texto completoBeck, James S. "Conceptual Foundations and Uses of Models in Pharmacokinetics". En Pharmacokinetics, 11–18. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4684-5463-5_2.
Texto completoRescigno, Aldo y Ajit K. Thakur. "Development of Compartmental Concepts". En Pharmacokinetics, 19–26. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4684-5463-5_3.
Texto completoThakur, Ajit K. "Modeling of Pharmacokinetic Data". En Pharmacokinetics, 27–59. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4684-5463-5_4.
Texto completoActas de conferencias sobre el tema "Pharmacokinetics"
Dol, F., G. Houin, D. Dupouy, C. Caranobe, Y. Cadroy, P. Sié y B. Boneu. "THE PHARMACOKINETICS OF 125-I DERMATAN SULFATE IN THE RABBIT". En XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643243.
Texto completoEvans, Conor L. "Quantifying human cutaneous pharmacokinetics". En Advanced Chemical Microscopy for Life Science and Translational Medicine 2021, editado por Garth J. Simpson, Ji-Xin Cheng y Wei Min. SPIE, 2021. http://dx.doi.org/10.1117/12.2577713.
Texto completoJohansson, Ann, Jenny Svensson, Stefan Andersson-Engels, Niels Bendsoe, Katarina Svanberg, Irving Bigio, Eleni Alexandratou et al. "mTHPC pharmacokinetics following topical administration". En Biomedical Optics 2006, editado por Gerard L. Coté y Alexander V. Priezzhev. SPIE, 2006. http://dx.doi.org/10.1117/12.647602.
Texto completoCaranobe, C., G. Houin, C. Picard, J. M. Pereillo y B. Boneu. "THE PHARMACOKINETICS OF 125I PENTOSAN POLYSULFATE IN THE RABBIT : EVIDENCE FOR A SATURABLE MECHANISM OF CLEARANCE". En XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643248.
Texto completoKasyanova, V. V. y I. N. Bazhukova. "Modeling of cerium oxide nanoparticles pharmacokinetics". En THE 2ND INTERNATIONAL CONFERENCE ON PHYSICAL INSTRUMENTATION AND ADVANCED MATERIALS 2019. AIP Publishing, 2020. http://dx.doi.org/10.1063/5.0032208.
Texto completoLee, Seok-Yong, Chang-Keun Cho, Pureum Kang, Eunvin Ko y Chou Yen Mu. "Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict the Pharmacokinetics of Irbesartan in DifferentCYP2C9Genotypes". En ASPET 2023 Annual Meeting Abstracts. American Society for Pharmacology and Experimental Therapeutics, 2023. http://dx.doi.org/10.1124/jpet.122.508580.
Texto completoAhmed, Nusrat, Yashpal S. Chhonker, Valentina Shakhnovich, Veronica Williams y Daryl J. Murry. "Development of a Physiologically Based Pharmacokinetic Model for Predicting Midazolam Pharmacokinetics in a Pediatric Population with Obesity". En ASPET 2024 Annual Meeting Abstract. American Society for Pharmacology and Experimental Therapeutics, 2024. http://dx.doi.org/10.1124/jpet.404.938920.
Texto completoKeith, Godfrey,. "Modelling the Double Peak Phenomenon in Pharmacokinetics". En Modeling and Control in Biomedical Systems, editado por Rees, Stephen, Chair Andreassen, Steen y Andreassen, Steen. Elsevier, 2009. http://dx.doi.org/10.3182/20090812-3-dk-2006.00022.
Texto completoFeizpour, Amin, Louise Bastholm, Troels T. Marstrand y Conor L. Evans. "Label-free Quantification of Pharmacokinetics in Skin". En Bio-Optics: Design and Application. Washington, D.C.: OSA, 2019. http://dx.doi.org/10.1364/boda.2019.jw3c.1.
Texto completoHovanessian, Vladimir A., Asatour Lalaian y Grigor Gyulkhandanyan. "Laser fluorescence investigation of chlorin e6 pharmacokinetics". En BiOS Europe '96, editado por Stanley B. Brown, Benjamin Ehrenberg y Johan Moan. SPIE, 1996. http://dx.doi.org/10.1117/12.260784.
Texto completoInformes sobre el tema "Pharmacokinetics"
Hawkins, David R. Determination of Drug Pharmacokinetics and Metabolic Profile. Volume 2. Fort Belvoir, VA: Defense Technical Information Center, marzo de 1988. http://dx.doi.org/10.21236/ada192428.
Texto completoHeinen, Jessica. Process of Modeling Pharmacokinetics Using Nonlinear Mixed-Effect Models. Ames (Iowa): Iowa State University, enero de 2020. http://dx.doi.org/10.31274/cc-20240624-1156.
Texto completoGurley, L. R., K. O. Umbarger, J. M. Kim, E. M. Bradbury y B. E. Lehnert. Staurosporine analysis and its pharmacokinetics in the blood of rats. Office of Scientific and Technical Information (OSTI), julio de 1994. http://dx.doi.org/10.2172/10160825.
Texto completoCheung, Nai-Kong V., Shakeel Modak, Yukang Lin, Hongfen Guo, Pat Zanzonico, John Chung, Yuting Zuo et al. Pharmacokinetics of Genetically Engineered Antibody Forms Using Positron Emission Tomography. Office of Scientific and Technical Information (OSTI), agosto de 2004. http://dx.doi.org/10.2172/828873.
Texto completoKarna, Shravya y Alex Konstantatos. Methadone and Buprenorphine for Management of Acute Postoperative Pain. World Federation of Societies of Anaesthesiologists, mayo de 2022. http://dx.doi.org/10.28923/atotw.472.
Texto completoKamimori, Gary H. Effect of Time of Menstrual Cycle on Drug Pharmacokinetics and Pharmacodynamics. Fort Belvoir, VA: Defense Technical Information Center, mayo de 2001. http://dx.doi.org/10.21236/ada409105.
Texto completoKornhauser, David M., Brent G. Petty y Paul S. Lietman. Pharmacokinetics and Pharmacodynamics of Sustained Low-Dose Intravenous Infusions of Pyridostigmine. Fort Belvoir, VA: Defense Technical Information Center, mayo de 1993. http://dx.doi.org/10.21236/ada530411.
Texto completoCarpenter, Hillary M. y Lawrence R. Curtis. Pharmacokinetics of Lipophilic Agents Following Preexposure: Non-Cytochrome P-450 Mediated Mechanisms. Fort Belvoir, VA: Defense Technical Information Center, mayo de 1990. http://dx.doi.org/10.21236/ada225356.
Texto completoGorden, Patrick J., Michael D. Kleinhenz, Larry W. Wulf, Butch KuKanich, Chang J. Lee, Chong Wang y Johann F. Coetzee. Altered Plasma Pharmacokinetics of Ceftiofur Hydrochloride in Cows Affected with Severe Clinical Mastitis. Ames (Iowa): Iowa State University, enero de 2016. http://dx.doi.org/10.31274/ans_air-180814-216.
Texto completoLi, Haobo, Zhu Zhang, Haoyi Weng, Yuting Qiu, Pablo Zubiaur, Yu Zhang, Guohui Fan et al. Association of rs2244613 Polymorphism with Dabigatran Pharmacokinetics and Safety: A Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, junio de 2022. http://dx.doi.org/10.37766/inplasy2022.6.0027.
Texto completo